Stocks
Change Healthcare Financial Statements (CHNG) |
||||||||||
| Change Healthcaresmart-lab.ru | % | 2020 | 2021 | 2021 | 2022 | 2022 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 04.06.2020 | 27.05.2021 | 29.07.2021 | 31.03.2022 | 26.05.2022 | 04.08.2022 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 196.8 | 3 090 | 3 090 | 3 481 | 3 481 | 3 609 | |||
| Operating Income, bln rub | -711.2 | 100.1 | 100.1 | 136.8 | 225.5 | 195.5 | ||||
| EBITDA, bln rub | ? | -1 043 | 690.2 | 690.2 | 907.3 | 907.3 | 1 402 | |||
| Net profit, bln rub | ? | -947.6 | -112.2 | -112.2 | -57.4 | -154.6 | -77.4 | |||
| OCF, bln rub | ? | -153.9 | 586.2 | 586.2 | 696.9 | 696.9 | 1 121 | |||
| CAPEX, bln rub | ? | 13.0 | 246.4 | 246.4 | 276.3 | 276.3 | 518.8 | |||
| FCF, bln rub | ? | -166.9 | 339.8 | 339.8 | 420.6 | 420.6 | 602.4 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 246.9 | 1 505 | 1 505 | 3 344 | 3 344 | 2 606 | ||||
| Cost of production, bln rub | 84.1 | 1 532 | 1 532 | 0.000 | 0.000 | 833.6 | ||||
| R&D, bln rub | 11.6 | 227.0 | 227.0 | 277.9 | 277.9 | 293.0 | ||||
| Interest expenses, bln rub | 16.7 | 245.2 | 245.2 | 234.2 | 234.2 | 227.7 | ||||
| Assets, bln rub | 10 107 | 10 113 | 10 113 | 9 932 | 9 932 | 9 637 | ||||
| Net Assets, bln rub | ? | 3 285 | 3 252 | 3 252 | 3 276 | 3 276 | 3 291 | |||
| Debt, bln rub | 4 989 | 4 793 | 4 793 | 4 664 | 4 664 | 4 560 | ||||
| Cash, bln rub | 410.4 | 113.1 | 113.1 | 252.3 | 252.3 | 94.0 | ||||
| Net debt, bln rub | 4 579 | 4 680 | 4 680 | 4 412 | 4 412 | 4 466 | ||||
| Ordinary share price, rub | 9.99 | 22.1 | 22.1 | 21.8 | 21.8 | 24.8 | ||||
| Number of ordinary shares, mln | 137.0 | 320.8 | 137.0 | 324.0 | 324.0 | 326.6 | ||||
| Market cap, bln rub | 1 369 | 7 089 | 3 028 | 7 063 | 7 063 | 8 086 | ||||
| EV, bln rub | ? | 5 947 | 11 769 | 7 707 | 11 475 | 11 475 | 12 552 | |||
| Book value, bln rub | -4 876 | -5 044 | -5 044 | -4 536 | -4 536 | -4 398 | ||||
| EPS, rub | ? | -6.92 | -0.35 | -0.82 | -0.18 | -0.48 | -0.24 | |||
| FCF/share, rub | -1.22 | 1.06 | 2.48 | 1.30 | 1.30 | 1.84 | ||||
| BV/share, rub | -35.6 | -15.7 | -36.8 | -14.0 | -14.0 | -13.5 | ||||
| EBITDA margin, % | ? | -530.2% | 22.3% | 22.3% | 26.1% | 26.1% | 38.8% | |||
| Net margin, % | ? | -481.5% | -3.63% | -3.63% | -1.65% | -4.44% | -2.14% | |||
| FCF yield, % | ? | -12.2% | 4.79% | 11.2% | 5.95% | 5.95% | 7.45% | |||
| ROE, % | ? | -28.8% | -3.45% | -3.45% | -1.75% | -4.72% | -2.35% | |||
| ROA, % | ? | -9.38% | -1.11% | -1.11% | -0.58% | -1.56% | -0.80% | |||
| P/E | ? | -1.44 | -63.2 | -27.0 | -123.1 | -45.7 | -104.5 | |||
| P/FCF | -8.20 | 20.9 | 8.91 | 16.8 | 16.8 | 13.4 | ||||
| P/S | ? | 6.95 | 2.29 | 0.98 | 2.03 | 2.03 | 2.24 | |||
| P/BV | ? | -0.28 | -1.41 | -0.60 | -1.56 | -1.56 | -1.84 | |||
| EV/EBITDA | ? | -5.70 | 17.1 | 11.2 | 12.6 | 12.6 | 8.95 | |||
| Debt/EBITDA | -4.39 | 6.78 | 6.78 | 4.86 | 4.86 | 3.19 | ||||
| R&D/CAPEX, % | 88.9% | 92.1% | 92.1% | 100.6% | 100.6% | 56.5% | ||||
| CAPEX/Revenue, % | 6.61% | 7.97% | 7.97% | 7.94% | 7.94% | 14.4% | ||||
| Change Healthcare shareholders | ||||||||||
